0001571049-15-005430.txt : 20150701 0001571049-15-005430.hdr.sgml : 20150701 20150701172907 ACCESSION NUMBER: 0001571049-15-005430 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150630 FILED AS OF DATE: 20150701 DATE AS OF CHANGE: 20150701 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: APPLIED DNA SCIENCES INC CENTRAL INDEX KEY: 0000744452 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380] IRS NUMBER: 592262718 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 50 HEALTH SCIENCES DRIVE CITY: STONY BROOK STATE: NY ZIP: 11790 BUSINESS PHONE: 631-240-8800 MAIL ADDRESS: STREET 1: 50 HEALTH SCIENCES DRIVE CITY: STONY BROOK STATE: NY ZIP: 11790 FORMER COMPANY: FORMER CONFORMED NAME: PROHEALTH MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 20010504 FORMER COMPANY: FORMER CONFORMED NAME: DCC ACQUISITION CORP DATE OF NAME CHANGE: 19990211 FORMER COMPANY: FORMER CONFORMED NAME: DATALINK CAPITAL CORP/TX/ DATE OF NAME CHANGE: 19980306 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Liang Ming-Hwa Benjamin CENTRAL INDEX KEY: 0001624582 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36745 FILM NUMBER: 15966220 MAIL ADDRESS: STREET 1: C/O APPLIED DNA SCIENCES, INC. STREET 2: 50 HEALTH SCIENCES DRIVE CITY: STONY BROOK STATE: NY ZIP: 11790 4 1 t82683b-liang630.xml FORM 4 X0306 4 2015-06-30 0 0000744452 APPLIED DNA SCIENCES INC APDN 0001624582 Liang Ming-Hwa Benjamin 50 HEALTH SCIENCES DRIVE STONY BROOK NY 11790 0 1 0 0 Strategic Tech. Dev. Officer Employee Stock Option (right to buy) 3.60 2015-06-30 4 D 0 166667 0 D 2015-06-30 Common Stock 166667 0 D Employee Stock Option (right to buy) 3.60 2015-06-30 4 A 0 166667 0 A 2015-06-30 2020-06-30 Common Stock 166667 166667 D The two reported transactions involve an amendment of an outstanding option to extend the expiration date of such option from June 30, 2015 to June 30, 2020, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on July 1, 2010 and provided for vesting (i) with respect to 25% of the underlying shares on the original date of grant and (ii) with respect to the remaining underlying shares, ratably each anniversary thereafter until fully vested on the third anniversary of the original date of grant. /s/ Beth Jantzen, Attorney-in-Fact 2015-07-01